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Abstract
Background: Cough is one of the most common respiratory symptoms and is well characterized in specialized
cough clinics with high success rates of diagnosis and treatment. However, there is a paucity of data regarding
cough in primary care settings. The present study aimed at investigating clinical epidemiology of cough through a
national study of two questionnaire surveys sent to primary care physicians in China.
Methods: Approximately 18,000 subjects recruited were having daytime or night symptoms of cough and
diagnoses of respiratory disease from February 2005 to April 2006 as Survey 1 and from June 2007 to December
2007 as Survey 2. Patients suffering from respiratory malignancy, hyperthyroidism, hypertension, heart disease,
diabetes, severe hypohepatia or renal dysfunction, pregnancy, possible pregnancy or lactation, neutropenia were
not eligible. Information regarding demography, history of allergies, symptomatic profile, treatment and curative
effects for cough was elicited.
Results: 8216 questionnaires were collected in Survey 1 and 9711 in Survey 2. The mean values of ages were 25.7
and 22.3 years old, respectively. Symptoms included expectoration (74% and 76%), wheeze (59% and 74%),
breathlessness (22% and 26%), chest pain (9% and 13%) and fever (15% and 18%). About 15% and 23% patients
had hypersusceptibility, of whom 6% to 17% had a family history. More than 50% of the cases had histories of
allergic rhinitis, asthma, conjunctivitis or atopic dermatitis. Asthma, COPD, and bronchitis were dominant etiologies
of cough. Procaterol or the combination of antibiotics and steroids were used as the treatment.
Conclusion: Causes and outcomes of cough differed with ages and time in this particular national study, while
successful and precise diagnosis and management of cough in primary care settings need to be further improved
in China.
Introduction
Cough is one of the most common respiratory symptoms
encountered by clinicians [1], with the reported preva-
lence varying between 5% and 40% [2-4]. Cough is also
one of the critical factors affecting the quality of life in
patients with respiratory diseases. Cough management
has massive economic consequences. The first guideline
on the management of cough with a significant positive
impact was championed in 1998 [5], followed by the pub-
lication of other guidelines on chronic cough [6-9]. The
Chinese Medical Association published “Diagnosis and
treatment guide (draft) of cough” in 2005 [10], and then
the American College of Chest Physicians published
evidence-based guidelines for diagnosis and treatment of
acute cough, subacute cough, and chronic cough in
adults and chronic cough in children in 2006 [1,6,11].
Over-the-counter combination cough medication such
as cough syrup including traditional Chinese medicine is
usually the first choice in China. The majority of people
with cough who consulted a health care professional
received the diagnosis and was informed that over the
counter cough medications could relieve the symptoms.
However, there are still a number of those with unclear
diagnosis or failure to respond to therapy. The present
study aimed at investigating clinical epidemiology of
cough through a national study of two questionnaire sur-
veys sent to primary care physicians in China. Approxi-
mately 18,000 subjects with daytime or night symptoms of
cough and with diagnoses of respiratory disease were
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any medium, provided the original work is properly cited.recruited for questionnaires from February 2005 to April
2006 as Survey 1 and from June 2007 to December 2007
as Survey 2. It provided further information about the
demographic and symptomatic profile in the population
and curative effects for cough in Chinese patients with
respiratory diseases. This is one of the national projects
organized by the Chinese Medical Doctor Association in
order to obtain a better understanding of coughs while
hoping the results could lead to new ideas and plans to
explore in regard to molecular mechanisms and therapies.
Methods
Patients
T h ep r e s e n ts t u d yi d e n t i f i e dc l i n i c a lc h a r a c t e r i s t i c so f
patients with cough from a nationwide-based survey
conducted by the Chinese Medical Doctor Association.
Subjects recruited had daytime or nighttime symptoms of
cough and diagnoses of respiratory diseases, from 85
primary care medical centers. The 85 clinics are primary
care centers chosen from the north and south of China
as representatives in China. One survey started from
February 2005 to April 2006 was named Survey 1 and one
from June 2007 to December 2007 was named Survey 2.
The two surveys were performed at the same 85 clinics.
There was no overlap of the two surveys. The reason for
calculating using two surveys was to see the improvement
of health care and medical care inbetween the two time
periods. Patients were provided with written information
prior to obtaining oral consent. The study is a question-
naire survey aimed at investigating the clinical epidemiol-
ogy of the cough for patients when first visiting the
primary care center. Information on patient health care
data, e.g. numbers, home address, phone number and
others, was protected.
Evaluation Scores
Physicians were invited to complete and follow up the
cough questionnaires and were then completed by the
referred patients who had been in primary care settings
during the first time. After then, they were continuously
followed up for an additional 14 days, in order to audit
social and demographic factors as well as qualitative mea-
sures of responses to treatment. The physicians filled out
the questionnaires. Sections of open questions were
asked, including demographic details, symptoms, history
of the cough, hypersusceptibility patterns, and treatment
outcomes. Hypersusceptibility was defined as a cough
condition of abnormal susceptibility to stimuli that are
entirely innocuous in the normal individual. Cough
severity was assessed on a scale of 0 (no cough) to 3
(severe cough) and recorded on a daily record. Effective-
ness was evaluated as cured (symptom score decreased to
0), markedly improved (symptom score decreased ≥ 4),
improved (Symptom score decreased ≥ 2), or no effect
(unchanged or aggravated). Adverse events were elicited
at each visit by enquiring about the side effects of therapy
recorded from a symptom checklist.
Statistics
Data were analyzed by the two-sided test and p value less
than 0.05 was considered significant. Non-parametric sta-
tistics rank sum test was used for the analysis of recovery
percentage. The quota target was used and described by
statisticians, including the computation arithmetic mean
value, the standard deviation, the median, the minimum
value, the maximum value. The example number was
calculated and the percentage of corresponding was classi-
fied with the identification target. Data was analyzed using
the SAS 9.1.2 program by Health Statistics Laboratory of
Chinese Center for Disease Control and Prevention.
Results
Of 18000 questionnaires, 8216 were received by the end of
April, 2006, and 9711 by the end of Dec 2007, respectively.
There were 4655 males and 3561 females with a mean age
of 25.7 (standard deviation 24, range 1-98 years) in Survey
1 with 8216 patients. Of them, 46% were less than 10
years old (Table 1 and Table 2). There were 5331 males
and 4010 females with a mean age of 22.3 years (standard
deviation 22 years) in Survey 2 with 9711 patients, among
whom the age of 425 patients were not recorded.
T h ec o u g hw a sr e p o r t e dt ob ep r o d u c t i v ei n6 2 5 6o f
8216 patients (76%) with complaint of wheeze 59%,
breathlessness 22%, chest pain 9% and fever 18% in Survey
1, while cough (74%), wheeze (74%), breathlessness (26%),
chest pain (13%) and fever (15%) were noticed in Survey 2.
Of 8216 patients in Survey 1, 1919 (23%) had hypersus-
ceptibility and 1359 (17%) had a family history of hyper-
susceptibility. Of 9177 patients in Survey 2, 1444 (15%)
had hypersusceptibility and 621 (6%) had a family history
of hypersusceptibility. More than 50% of cases had a his-
tory of allergic rhinitis, asthma, allergic conjunctivitis or
atopic dermatitis (Table 3). Inclusion subjects were given a
Table 1 Characteristic of the subjects in Survey 1
Age Male Female Total
Years Cases Percentage Cases Percentage Cases Percentage
0-10 2102 45.2% 1710 48.0% 3812 46.4%
11-20 249 5.3% 196 5.5% 445 5.4%
21-30 279 6.0% 281 7.9% 560 6.8%
31-40 519 11.1% 397 11.1% 916 11.2%
41-50 492 10.6% 299 8.4% 791 9.6%
51-60 382 8.2% 239 6.7% 621 7.6%
61-70 321 6.9% 151 4.2% 472 5.7%
71-80 212 4.6% 107 3.0% 319 3.9%
81-90 99 2.1% 181 5.1% 280 3.4%
Total 4655 100% 3561 100% 8216 100%
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described the details of diagnosis. Tubercular pleurisy, sto-
matitis, acute pharyngitis, hypertension of pulmonary
artery or fewer were listed in the section of others.
Patients were treated with Procaterol, of whom 1098 in
Survey 1 and 1046 in Survey 2 also had a combination of
drugs, including expectorant (Ambroxol, Bromhexine,
Carbocisteine), methylxanthines (Aminophylline, Theo-
phylline), antihistamines (Cetirizine, Ketotifen, Cypro-
hentadine, Loratadine, Chlorphenamine, Tranilast),
leukotriene modifiers (Montelukast), beta2 agonists
(Salbutamol), inhaled long-acting beta2 agonists, Same-
trol/Fluticasone, Formoferol/Budesonide, anticholinergics
(Ipratropine). Combined drugs also included cough syrup
(e.g. graifenesin, methylephedrine, chlorphenamine
syrup, dextromethorphan hydrobromide with chlorphe-
niramine maleate, or pseudoe phedrine hydiochloride
solution), Asmeton, Chinese traditional medicine, inhaled
steroids (e.g. budesonide, fluticasone, and beclometha-
sone dipropionate), systemic steroids (e.g. methylpredni-
solone, prednisone, and dexamethasone), anti-virus
(Ribavirin), or antibiotics(e.g. macrocyclic lactone, quino-
lone, cephalosporin, benzylpenicillin, and others), as
shown Table 5.
The daily cough diary showed a rapid and highly signifi-
cant reduction in the cough score (Table 6 and Table 7).
Of them, 83% in Survey 1 and 92% in Survey 2 had no
symptom during the daytime after 14 days of treatment,
while 82% in Survey 1 and 94% in Survey 2 had no symp-
tom during the night. There was a significant difference
between before and after the treatments (p < 0.05 or 0.01,
respectively). No patient dropped out because of severe
adverse events.
Discussion
Cough is an important defensive reflex of the respiratory
tract to clean up and protect the upper airway, while also
being the commonest symptom for which patients seek
medical advice. Causes and outcomes of cough differ
Table 2 Characteristic of the subjects in Survey 2
Age Male Female Total
Cases Percentage Cases Percentage Cases Percentage
0-10 2439 45.5% 2252 55.8% 4691 50.5%
11-20 812 15.2% 539 13.4% 1351 14.5%
21-30 216 4.2% 175 4.2% 391 4.2%
31-40 426 8.1% 269 6.6% 695 7.5%
41-50 535 9.9% 249 6.2% 784 8.4%
51-60 361 6.7% 208 5.1% 569 6.1%
61-70 297 5.5% 154 3.8% 451 4.9%
71-80 201 3.8% 132 3.2% 333 3.6%
81-90 14 0.2% 7 0.1% 21 0.2%
Total 5301 100% 3985 100% 9286 100.0%
Table 3 History of diseases in subjects with cough
Disease Survey 1 Survey 2
Cases Percentage Cases Percentage
Allergic rhinitis 1359 16.5% 1972 20.3%
Asthma 3202 39.0% 6236 64.2%
Allergic conjunctivitis 88 1.1% 227 2.3%
Atopic dermatitis 120 1.5% 104 1.1%
Table 4 Diagnosis of inclusion subjects
Diagnosis Survey 1 Survey 2
Cases Percentage Cases Percentage
Influenza 2 0.02% 1 0.01%
Rhinitis 28 0.34% 30 0.31%
Bronchial hyperreactivity 19 0.23% 0 0.00%
COPD & Asthma 90 1.10% 0 0.00%
Chronic bronchitis 124 1.51% 105 1.08%
Pneumonia 290 3.53% 87 0.90%
Allergic cough 334 4.07% 301 3.10%
Asthmatoid bronchitis 341 4.15% 292 3.01%
Common cold 394 4.80% 31 0.32%
Chronic cough 520 6.33% 249 2.56%
Acute bronchitis 932 11.34% 1000 10.30%
Asthma (except CVA) 1799 21.89% 4521 46.56%
COPD 1303 15.86% 1135 11.69%
Cough variant asthma(CVA) 1723 20.97% 1563 16.10%
others 317 3.86% 400 4.08%
Total 8216 100.00% 9711 100.00%
Table 5 Treatments of inclusion subjects
Treatment Survey 1 Survey 2
Cases Percentage Cases Percentage
Expectorant 194 2.36% 1 0.01%
Methylxanthines 126 1.53% 39 0.40%
Antihistamines 197 2.40% 48 0.49%
Leukotriene modifiers 104 1.27% 151 1.55%
SABAS 43 0.52% 184 1.89%
LABA 34 0.41% 53 0.55%
Anticholinergics 36 0.44% 2 0.02%
Combination Drugs 82 1.00% 1 0.01%
Chinese traditional medicine 169 2.06% 14 0.14%
Inhaled steroids 180 2.19% 225 2.32%
Systemic Corticosteroids 45 0.55% 22 0.23%
Anti-virus 6 0.07% 0 0.00%
Macrocyclic
lactone
88 1.07% 5 0.05%
Quinolone 51 0.62% 0 0.00%
Antibiotics Cephalosporin 267 3.25% 243 2.50%
Benzylpenicillin 45 0.55% 31 0.32%
others 12 0.15% 72 0.74%
Others drugs (unknown) 414 5.04% 19 0.20%
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vary with time (e.g. seasonality) and habits (e.g. smoking,
occupation, body weight, use of drug etc.). Children
b e l o w1 0y e a r sm a yh a v em o r ee p i s o d e so fb r o n c h i o l i t i s
and asthma, which is the reason why their prevalence is
high among both surveys in the present, while the adults
suffer more from pneumonia and other chronic condi-
tions. One of the common causes is chronic upper airway
cough syndrome, previously referred to as postnasal drip
syndrome, secondary to rhinosinus diseases, common
cold, asthma, gastroesophageal reflux disease, bronchitis
(e.g. acute bronchitis, chronic bronchitis, acute exacerba-
tion of chronic bronchitis, or nonasthmatic eosinophilic
bronchitis), bronchiectasis, post infectious cough, or
others [12]. Thus, it is unexpectedly challenging for clini-
cians to define the etiology and pathogenesis of coughs
in addition to selecting the optimal treatment in primary
care settings. According to our knowledge, the present
study incorporates the largest population sample yet to
study the clinical epidemiology of coughs, which in turn
can provide an overall figure indicating personal feelings,
signs and clinical indications of coughs in primary care
settings.
Subjects recruited in the present study had daytime or
night symptoms of cough and diagnoses of respiratory
disease, of whom about half were children. The accom-
panied symptoms included expectoration, fever, chest
pain, usually indicative of the respiratory infection,
Table 6 Daytime cough symptom assessment
Days Cases in survey 1 Cases in survey 2
No symptom Mild cough Moderate cough Severe cough No symptom Mild cough Moderate cough Severe cough
0 34 807 3146 3926 12 182 2561 6463
1 35 701 2978 3617 7 206 2475 5764
2 87 910 3493 2903 69 557 3337 4568
3 218 1291 4075 1890 227 1016 4371 3156
4 366 1671 4495 846 145 1426 6034 673
5 521 2070 4326 413 309 2390 5394 173
6 805 2692 3682 183 633 3342 4229 65
7 1151 3482 2896 76 1326 3777 3473 42
8 1449 4035 1756 41 890 4810 1614 29
9 1895 4250 1077 24 1438 5065 647 26
10 2382 4199 605 13 2240 4401 251 20
11 3166 3075 304 5 3058 3617 102 19
12 4370 2655 123 7 4758 1859 48 19
13 5280 1799 62 4 5056 966 33 19
14 6083 1388 46 5 5540 704 33 19
Table 7 Night cough symptom assessment
Days Cases in survey 1 Cases in survey 2
No symptom Mild cough Moderate cough Severe cough No symptom Mild cough Moderate cough Severe cough
0 149 819 2939 3942 43 239 2471 6441
1 80 818 2632 3756 39 272 2424 5690
2 167 944 2967 3165 88 615 2830 4971
3 318 1190 3382 2349 236 1110 4274 3132
4 466 1512 3944 1310 171 1467 5455 1159
5 640 1800 4126 637 339 2198 5420 296
6 895 2223 3826 287 555 3124 4483 92
7 1276 2780 3272 133 1379 3777 3423 39
8 1513 3180 2373 68 978 4664 1747 23
9 1809 3655 1605 28 1395 4759 1091 19
10 2151 3944 936 14 2048 4518 392 15
11 2704 3809 495 4 3096 3591 132 15
12 3711 3077 214 1 4651 1983 48 17
13 4778 2121 87 1 5030 998 28 17
14 5903 1417 48 0 5716 531 24 18
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panied with COPD and asthma. The two common dis-
eases were COPD and asthma including cough variant
asthma. Breathlessness and cough may be the clinical
indicators of COPD or asthma exacerbations [13], while
acute bronchitis should not be diagnosed until the com-
mon cold, asthma, and an acute exacerbation of chronic
bronchitis have been ruled out [14]. However, it was
often over-diagnosed, leading to the abuse of antibiotics.
About 10% of patients were diagnosed as acute bronchi-
tis in the Surveys, which was a lower percentage than
that of COPD and asthma. Nasal disease was an impor-
tant risk factor of cough, especially of chronic cough. It
would be more valuable for the therapeutic strategies to
further distinguish acute and chronic cough, rhinitis and
other nasal disease if the proportion was large enough.
Hypersusceptibility has been suggested as one of major
challenging factors in cough. We found that more than
half of the patients with cough had a history of allergic rhi-
nitis, asthma, allergic conjunctivitis or atopic dermatitis.
About 15% to 23% patients had hyper-susceptibility, while
6% to 17% had a family history of hyper-susceptibility.
More patients had a history of asthma in Survey 2 (64%)
than in Survey 1 (39%). Allergic rhinitis is a common
cause of postnasal drip and coughs, with a high prevalence
in patients with asthma [15]. Patients with allergic rhinitis
should be identified and clarified in the future study, in
order to evaluate the significance and difference of allergic
diseases in cough.
Procaterol was used as the treatment of patients,
although the symptom of acute cough was sometimes
automatically cured [16]. Responses to the used treatment
were rapid and efficient, evidenced by the fact that 83%
and 92% of patients in Surveys 1 and 2, respectively, had
no daytime symptoms and 82% and 94% had no night
symptoms after 14 days of treatment. Although our data
showed that Procaterol could improve the symptom of
cough in patients with respiratory diseases, we do not
know the exact effects of the drug as our study was not a
randomized controlled trial. Antibiotics were hardly effec-
tive for chronic cough and acute cough caused by the
common cold, acute bronchitis, asthma, mild exacerba-
tions of chronic bronchitis related to smoking, or environ-
mental irritants [17,18]. However, the application of
antibiotics could be beneficial for upper airway cough syn-
drome resulted from bacterial sinusitis, and infection in
the lower respiratory tract (whooping cough), if given
early. The prescription rate of antibiotics was about 4-6%
in patients with cough, which was considered as accepta-
ble according to the conditions of the patients studied.
Inhaled steroids were used in about 2% of patients, while
systemic corticosteroids in 0.6%.
However, a number of limitations in the present study
should be improved in future studies. For example, such
cross-sectional studies should be followed up longitudin-
ally, results based on self-reports should be compared
with clinical information, including physical examina-
tions, imaging and biochemical analyses. More diagnoses
should be included in the questionnaire form, including
pneumonia, common cold, acute bronchitis, and chronic
bronchitis, even though it may be difficult to confirm
those diagnoses. More attention on etiology and patho-
genesis of cough should be considered as well as further
education on cough management should be delivered to
physicians working in primary care settings.
Conclusion
In conclusion, cough causes a high level of morbidity in
the community, annually resulting in massive health econ-
omy consequences. Demography and symptomatology
seem to be similar to that reported in specialist hospital
centers, but successful and precise diagnosis and treatment
of cough was not as satisfactory. Management of cough in
primary care needs to be improved in China.
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